Indeed we observed HCMV protein expression in the majority of CD133+ medulloblastoma cells whereas in neuroblastoma this number varied between 4-34% depending on cell line and sampling time ([12], and unpublished observations). This evidence concerns the gene PROM1 and medulloblastoma.